Sedative-Anxiolytic Effects on Simulated Driving Performance
Public ClinicalTrials.gov record NCT03297944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Alprazolam and Simulated Driving Performance: Next Day Effects
Study identification
- NCT ID
- NCT03297944
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Marion Coe
- Other
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- Alprazolam 0.5mg (0.5ALP/PLC) Drug
- Alprazolam 1mg (1ALP/PLC) Drug
- Alprazolam 1mg (PLC/ALC) Drug
- Alprazolam 2mg (2ALP/PLC) Drug
- Placebo (PLC/PLC) Drug
- Zolpidem 10mg (ZOL/PLC) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2017
- Primary completion
- Oct 24, 2018
- Completion
- Oct 24, 2018
- Last update posted
- Jan 28, 2020
2017 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center on Drug and Alcohol Research | Lexington | Kentucky | 40508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03297944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 28, 2020 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03297944 live on ClinicalTrials.gov.